1. Home
  2. QTRX vs DNA Comparison

QTRX vs DNA Comparison

Compare QTRX & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QTRX
  • DNA
  • Stock Information
  • Founded
  • QTRX 2007
  • DNA 2008
  • Country
  • QTRX United States
  • DNA United States
  • Employees
  • QTRX N/A
  • DNA N/A
  • Industry
  • QTRX Biotechnology: Laboratory Analytical Instruments
  • DNA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • QTRX Industrials
  • DNA Health Care
  • Exchange
  • QTRX Nasdaq
  • DNA Nasdaq
  • Market Cap
  • QTRX 492.0M
  • DNA 423.5M
  • IPO Year
  • QTRX 2017
  • DNA N/A
  • Fundamental
  • Price
  • QTRX $15.09
  • DNA $8.39
  • Analyst Decision
  • QTRX Strong Buy
  • DNA Hold
  • Analyst Count
  • QTRX 4
  • DNA 7
  • Target Price
  • QTRX $23.00
  • DNA $48.17
  • AVG Volume (30 Days)
  • QTRX 372.5K
  • DNA 776.0K
  • Earning Date
  • QTRX 11-12-2024
  • DNA 11-12-2024
  • Dividend Yield
  • QTRX N/A
  • DNA N/A
  • EPS Growth
  • QTRX N/A
  • DNA N/A
  • EPS
  • QTRX N/A
  • DNA N/A
  • Revenue
  • QTRX $129,330,000.00
  • DNA $184,335,000.00
  • Revenue This Year
  • QTRX $13.56
  • DNA N/A
  • Revenue Next Year
  • QTRX $16.61
  • DNA $12.63
  • P/E Ratio
  • QTRX N/A
  • DNA N/A
  • Revenue Growth
  • QTRX 15.52
  • DNA N/A
  • 52 Week Low
  • QTRX $10.50
  • DNA $5.26
  • 52 Week High
  • QTRX $29.70
  • DNA $75.20
  • Technical
  • Relative Strength Index (RSI)
  • QTRX 69.72
  • DNA 54.01
  • Support Level
  • QTRX $12.80
  • DNA $7.43
  • Resistance Level
  • QTRX $13.73
  • DNA $8.60
  • Average True Range (ATR)
  • QTRX 0.69
  • DNA 0.60
  • MACD
  • QTRX 0.31
  • DNA -0.01
  • Stochastic Oscillator
  • QTRX 88.89
  • DNA 41.38

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory, Homebrew - Custom Assay Development, and Uman NF-Light.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.

Share on Social Networks: